Drug Database
Back to search

Canada· CA-DIN-02229048

ISOVUE 370 INJECTION

A iopamidol product containing iopamidol, registered in Canada by BRACCO IMAGING CANADA. The same ATC class is registered in 12 of our 19 countries.

ATC V08AB04

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedISOVUE 370 INJECTIONATCV08AB04REGISTER NO.CA-DIN-02229048PACKS LISTED0CHECKEDOctober 1, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about iopamidolAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Iopamidol is registered in 12 of 19 countries.

Countries holding a registration under ATC V08AB04 (iopamidol), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 6 of them publish a price we can compare per daily dose
Search iopamidol products by name

Iopamidol · ATC V08AB04

12 / 19 countries

  • Belgiumprice
  • Canada
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
IOPAMIDOL
Manufacturer
BRACCO IMAGING CANADA
Country
Canada (CA)
ATC code
V08AB04
ATC class
Iopamidol
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

367 interactions on record for iopamidol.

Graded by severity as the source publishes them — 286 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check iopamidol against other medicinesHow interaction checks work

Iopamidol · interactions on record

367 records

  • 286 severe
  • 54 moderate
  • 27 info

Most severe, free to view

  • MetoclopramideA03FA01severe
  • ThiethylperazinA04AB03severe
  • TriflupromazinA04AD06severe
  • DronabinolA04AD10severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Iopamidol in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All iopamidol products

Authorised across Europe · EMA

The same active substance is authorised in 18 EEA countries. Names it is sold under:

  • Austria · Gastromiro, Iopavision
  • Bulgaria · Scanlux, Йопамиро
  • Germany · Iopamidol Consentis Diagnostics, Iopamiro
  • Estonia · Iopamiro
  • Spain · Iopamiro, Scanlux
  • France · Clemis, Iopamiron
  • United Kingdom (Northern Ireland) · Gastromiro, Niopam
  • Greece · Iopamiro, Iopamiro 300
  • Croatia · Iopamiro
  • Hungary · Iopamiro, Scanlux
  • Ireland · Gastromiro, Niopam
  • Italy · Gastromiro, Iopamiro
  • Lithuania · Iopamiro
  • Netherlands · Iopamidol Adoh
  • Portugal · Gastromiro, Iopamiro
  • Romania · Iopamiro
  • Slovenia · Gastromiro, Iopamiro
  • Slovakia · Scanlux

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cdd2a474-8130-4d3f-bdad-2a8560ca54a1
GET /v1/drugs/cdd2a474-8130-4d3f-bdad-2a8560ca54a1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02229048",
  "form": "LIQUID",
  "class": "Human",
  "routes": [
    "INTRAVASCULAR"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "V08AB04",
  "schedule": [
    "Ethical"
  ],
  "drug_code": "43506",
  "strengths": [
    "76 %"
  ],
  "ahfs_class": null,
  "substances": [
    "IOPAMIDOL"
  ],
  "product_categorization": null
}
API referenceMCP serverPlans

See everything about iopamidol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console